Department of Radiation Oncology

Differences of the immune phenotype of breast cancer cells after ex vivo hyperthermia by warm-water or microwave radiation in a closed-loop system alone or in combination with radiotherapy (2020) Hader M, Savcigil DP, Rosin A, Ponfick P, Gekle S, Wadepohl M, Bekeschus S, et al. Journal article Cytotoxic and immunosuppressive inflammatory cells predict regression and prognosis following neoadjuvant radiochemotherapy of oesophageal adenocarcinoma (2020) Göbel HH, Büttner-Herold M, Fuhrich N, Aigner T, Grabenbauer GG, Distel L Journal article Magnetic resonance imaging for brain stereotactic radiotherapy - A review of requirements and pitfalls (2020) Putz F, Mengling V, Perrin R, Masitho S, Weissmann T, Roesch J, Bäuerle T, et al. Journal article, Review article Aggressive De-escalation in adjuvant Therapy for HPV-associated Oropharyngeal Cancer. Is Half of Everything enough? (2020) Hecht M, Semrau S Journal article, Editorial Consensus guidelines for the definition, detection and interpretation of immunogenic cell death (2020) Galluzzi L, Vitale I, Warren S, Adjemian S, Agostinis P, Martinez AB, Chan TA, et al. Journal article, Review article Graphene Oxide Nanosheets for Localized Hyperthermia-Physicochemical Characterization, Biocompatibility, and Induction of Tumor Cell Death (2020) Podolska M, Barras A, Alexiou C, Frey B, Gaipl U, Boukherroub R, Szunerits S, et al. Journal article Is it time to redefine the role of low-dose radiotherapy for benign disease? (2020) Montero A, Sabater S, Roedel F, Gaipl U, Ott O, Seegenschmiedt MH, Arenas M Journal article, Letter Comparison of Intrinsic PAM50 Gene Expression Analysis and Immunohistochemical Subtypes of Salivary Duct Carcinoma (2020) Erber R, Stoehr R, Haller F, Haderlein M, Hartmann A, Agaimy A Conference contribution Dose reduction to the swallowing apparatus and the salivary glands by de-intensification of postoperative radiotherapy in patients with head and neck cancer: First (treatment planning) results of the prospective multicenter DIREKHT trial (2020) Haderlein M, Speer S, Ott O, Lettmaier S, Hecht M, Semrau S, Frey B, et al. Journal article Randomized phase-III-trial of concurrent chemoradiation for locally advanced head and neck cancer comparing dose reduced radiotherapy with paclitaxel/cisplatin to standard radiotherapy with fluorouracil/cisplatin: The PacCis-trial (2020) Fietkau R, Hecht M, Hofner B, Lubgan D, Iro H, Gefeller O, Rödel C, et al. Journal article